Protective effects of glaucocalyxin A on the airway of asthmatic mice.
Protective effects of glaucocalyxin A on the airway of asthmatic mice.
复制标题
青萼素A对哮喘小鼠气道的保护作用
DOI:
10.1515/med-2022-0513
复制
发表时间:
2022
期刊:
影响因子:
2.1
通讯作者:
Yan, Guanghai
中科院分区:
文献类型:
--
作者:
Chen, Si;Piao, Ying;Song, Yilan;Wang, Zhiguang;Jiang, Jingzhi;Piao, Yihua;Li, Li;Xu, Chang;Li, Liangchang;Chi, Yongxue;Jin, Guihua;Yan, Guanghai
The aim of this study is to investigate the protective effects of glaucocalyxin A (GLA) on airways in mouse models of asthma, concerning the inflammatory mediators, Th1/Th2 subgroup imbalance, and Toll-like receptor 4 (TLR4)/NF-κB signaling pathway. Hematoxylin and eosin/periodic acid–Schiff staining was used to observe the pathological changes in lung tissues. Inflammatory cytokine contents in the bronchoalveolar lavage fluid were detected by enzyme-linked immunosorbent assay. Protein expression levels were detected with Western blot, immunohistochemistry, and immunofluorescence. In vivo studies showed that, in ovalbumin (OVA)-induced asthmatic mouse models, the GLA treatments reduced the airway hyperresponsiveness and the secretion of inflammatory cells, declined the proliferation of goblet cells, decreased the levels of IL-4, IL-5, and IL-13, and increased the contents of interferon-γ and IL-12. Moreover, GLA inhibited the protein expression levels of TLR4, MyD88, TRAF6, and NF-κB in OVA-induced asthmatic mouse models. Further in vitro studies showed that GLA inhibited the expression of NF-κB, p-IκBα, tumor necrosis factor-α, IL-6, and IL-1β and blocked the nuclear transfer of NF-κB in lipopolysaccharide-stimulated RAW264.7 macrophages. Conclusively, GLA can inhibit the inflammatory responses in OVA-induced asthmatic mice and inhibit the release of inflammatory factors in LPS-induced RAW264.7 macrophages, which may be related to the inhibition of TLR4/NF-κB signaling pathway.
登录
查看更多内容
DOI:
10.4168/aair.2016.8.2.132
发表时间:
2016-03
期刊:
Allergy, asthma & immunology research
影响因子:
--
作者:
Luo X;Hong H;Tang J;Wu X;Lin Z;Ma R;Fan Y;Xu G;Liu D;Li H
通讯作者:
Li H
DOI:
10.1155/2021/6644751
发表时间:
2021
期刊:
Evidence-based complementary and alternative medicine : eCAM
影响因子:
--
作者:
Piao Y;Jiang J;Wang Z;Wang C;Jin S;Li L;Li L;Piao H;Jin Z;Zhu L;Yan G
通讯作者:
Yan G
影响因子:
2.7
作者:
Chen, Tianyi;Liang, Weibo;Zhang, Lin
通讯作者:
Zhang, Lin
影响因子:
6
作者:
Han, Meihua;Li, Zhitao;Wang, Xiangtao
通讯作者:
Wang, Xiangtao
影响因子:
5.6
作者:
Hou, Xiaorong;Xu, Guang;Bai, Zhaofang
通讯作者:
Bai, Zhaofang